u/gustav_lindholm

I would not compare your numbers to that population.

This is the distinction that resolves most of the confusion here — average versus shape.

How long between the two A1c measurements?

A1c reflects average glycaemia over roughly the preceding three months, weighted towards the most recent weeks.

Agreed, and the glucose-dependence point is the reason the risk profile reads the way it does.

lead time quoted at checkout is the number to hold them to

That reads as a recommendation and the source pages deliberately are not. They are a record you use to make your own decision.

Yes. Spread across lots is the number that tells you about the process. A single high result tells you about a vial.

the interesting column is spread, not maximum

the diabetes trials report different endpoints from the obesity ones

That delay was at clearance, not with the carrier. The lane table separates them for exactly this reason.

Yes — a hold and a seizure are different events with different processes, and this board mixes them weekly.

Careful. "Nobody has tested Swiss Chems" is a statement about this board, not about the supplier. Say the first thing, not the second.

Fixing my own comment above: I said 3 orders and it is 28.

Agreed — and the corollary is that "no data" and "bad data" have to be written differently. The table separates them for exactly that reason.

registration number, then everything else

Hunan GoodPeptides Biotech came up in three threads the week I was ordering and I could not find a single independent result for them anywhere. Went with a documented supplier instead.